[Stereotaxic convergent-beam irradiation. Initial experiences with the SRS 200 system]

The system SRS 200 for the stereotactic convergent beam irradiation described in this paper has a stereotactic floor stand, which allows the high precision rotation of a secondary collimator around an isocenter. This system is used since 1991 at the University Hospital of Tübingen for the treatment of patients with solitary brain metastases, acoustic neurinomas and arteriovenous malformations.

The attainable accuracy of the mechanics and dosimetry was studied within the scope of extensive quality assurance measures during its installation and before each patients' irradiation. The individual treatment steps from radiotherapy planning to irradiation were evaluated by means of a specially developed head phantom. Since the installation of the SRS 200 a total of 50 patients (21 solitary brain metastases, 12 acoustic neurinomas, 17 arteriovenous malformations) has been treated with the system.

With 0.3 mm +/- 0.2 mm an excellent accuracy of the target point transfer and isocenter stability during irradiation was attained. The difference between calculated dose and dosimetric control measurements was smaller than 3%. The physical accuracy, however, is limited by the imaging resolution (CT and digital subtraction angiography). Of the patients 15% with solitary brain metastases developed complete remission, 20% partial remission and with 50% no further neurological deterioration was observed. Imaging revealed for 88% of the patients a reduced uptake of contrast medium or a regression of the tumor size. Six patients with acoustic neurinoma had anacusis already before radiotherapy. Regarding the other patients in the follow-up, hearing improved in 1 patient, 1 patient showed hearing deterioration, and all other patients hearing remained constant. MR and CT imaging revealed in 10 patients with acoustic neurinoma a reduced uptake of contrast medium and in 1 patient a tumor diminution. From the patients with arteriovenous malformation only 4 have been followed for more than 2 years after treatment. Therefore, statements about the rate of obliteration are not possible yet. Concerning pretherapeutic symptoms (headache 22%, convulsion 28%, neurological deficits 11%) 8/17 (47%) of the arteriovenous malformation patients showed an improvement, in 8 patients clinical findings were unchanged and 1 patient showed neurological deterioration.

The stereotactic system SRS 200 allows an excellent mechanical accuracy in the radiosurgery with linear accelerators.